英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
bickerer查看　bickerer　在百度字典中的解释百度英翻中〔查看〕
bickerer查看　bickerer　在Google字典中的解释Google英翻中〔查看〕
bickerer查看　bickerer　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • FAQs | Helsinn
    All Helsinn Code of Conduct and Third-Party Code of Conduct and Ethics violations should be reported, including but not limited to: – Ethics and compliance issues, fraud, misconduct, corruption, financial issues, conflicts of interest, insider trading, bribery, disclosure of confidential information
  • Helsinn Healthcare S. A. v. Teva Pharms. USA, Inc.
    Helsinn disagreed, arguing that such a construction would read the word “otherwise” out of the statute Helsinn argued that the associated-words canon requires the Supreme Court to read “otherwise available to the public” to limit the preceding terms in § 102 to disclosures that make the claimed invention available to the public
  • Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc. - Quimbee
    Get Helsinn Healthcare S A v Teva Pharmaceuticals USA, Inc , 139 S Ct 628 (2019), United States Supreme Court, case facts, key issues, and holdings and reasonings online today Written and curated by real attorneys at Quimbee
  • Scams Details - Better Business Bureau
    Description I am looking for a job and this is the email I received: HELSINN HEALTHCARE Sep 23, 2024, 10:39?AM (1 day ago) to me Dear Applicant, Your resume has been successfully reviewed and
  • HELSINN HEALTHCARE v. TEVA PHARMACEUTICALS USA INC (2019)
    Petitioner Helsinn Healthcare S A (Helsinn) is a Swiss pharmaceutical company that makes Aloxi, a drug that treats chemotherapy-induced nausea and vomiting Helsinn acquired the right to develop palonosetron, the active ingredient in Aloxi, in 1998 In early 2000, it submitted protocols for Phase III clinical trials to the Food and Drug
  • HELSINN HEALTHCARE S. A. v. TEVA PHARMACEUTICALS USA, INC. , No. 16-1284 . . .
    HELSINN HEALTHCARE S A v TEVA PHARMACEUTICALS USA, INC , No 16-1284 (Fed Cir 2017) Annotate this Case This opinion or order relates to an opinion or order originally issued on May 1, 2017 Download PDF
  • SUPREME COURT OF THE UNITED STATES - Bradley Arant Boult Cummings
    HELSINN HEALTHCARE S A v TEVA PHARMACEUTICALS USA, INC , ET AL CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT No 17–1229 Argued December 4, 2018—Decided January 22, 2019 Petitioner Helsinn Healthcare S A makes a treatment for chemother-apy-induced nausea and vomiting using the chemical palonosetron
  • Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA: Supreme Court . . .
    In 2001, Helsinn Healthcare S A (Helsinn), entered into license, sales, and purchase agreements with MGI Pharma Inc (MGI) The agreements granted MGI the right to distribute, market, and sell 0 25 milligram and 0 75 milligram doses of palonosetron, the active ingredient in Helsinn’s Aloxi, a drug used to treat nausea in chemotherapy patients
  • HELSINN HEALTHCARE S. A. v. GLAND PHARMA LIMITED
    HELSINN HEALTHCARE S A Defendant: GLAND PHARMA LIMITED: Case Number: 3:2022cv04635: Filed: July 18, 2022: Court: US District Court for the District of New Jersey: Presiding Judge: Lois H Goodman: Referring Judge: Zahid N Quraishi: Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
  • Helsinn Healthcare S. A. v. Teva Pharm. USA, Inc. - vLex
    I Petitioner Helsinn Healthcare S A (Helsinn) is a Swiss pharmaceutical company that makes Aloxi, a drug that treats chemotherapy-induced nausea and vomiting Helsinn acquired the right to develop palonosetron, the active ingredient in Aloxi, in 1998 In early 2000, it submitted protocols for Phase III clinical trials to the Food and Drug Administration (FDA), proposing to study a 0 25 mg





中文字典-英文字典  2005-2009